| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_382ccfc2ebebcaee15aa7cda4cee86bc |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-183
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-496
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0019 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-496
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-10 |
| filingDate |
2013-04-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ab37f9a7bbf14b27450d4c93dc2ebb35
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d16460b6916b1c1b6657d2a7a0f4dc8a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_22006898a2794f4d277fadd24c303b9d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d30c530065f6b4bf3b90eb8b15153f83 |
| publicationDate |
2020-11-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
CN-111888329-A |
| titleOfInvention |
injection |
| abstract |
The present invention solves the problem of providing a sustained-release injection as 7-[4-(4-benzo[b]thiophen-4-yl-piperazine-1-yl)butoxy]-1H-quinoline Long-acting forms of oxoline-2-one administration for the release of a therapeutically effective amount of 7-[4-(4-benzo[b]thiophen-4-yl-piperazin-1-yl)butoxy for at least one week base]-1H-quinolin-2-one. The present invention provides an injection whose concentration in blood can last for at least one week, the injection comprising 7-[4-(4-benzo[b]thiophen-4-yl-piperazine-1-yl)butoxy base]-1H-quinoline-2-ketone or its salt as an active ingredient. |
| priorityDate |
2012-04-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |